WallachBeth Capital upgraded DepoMed Inc (NASDAQ: DEPO) from Hold to Buy with a price target of $33.00.

For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.

Shares of DepoMed Inc closed at $21.21 yesterday.